SynthesisBMC musculoskeletal disorders2026
Deep learning in the diagnosis, staging, and prognosis of osteonecrosis of the femoral head: a systematic review.
Synthesis in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence Applications in MRI for the Diagnosis and Management of Osteonecrosis of the Femoral Head: A Comprehensive Review.Bioengineering (Basel, Switzerland) · 2026Review
- Non-femoral head MRI radiomics as a potential imaging biomarker for identifying osteonecrosis of the femoral head in systemic lupus erythematosus patients.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteonecrosis of the femoral head (ONFH) is a progressive ischemic bone disorder that often leads to structural collapse and early arthroplasty in adults. Early detection and accurate staging are essential for joint-preserving management. Deep learning (DL) has shown high promise in musculoskeletal imaging; however, the methodological quality and How well these ONFH-related DL models translate to clinical practice remain unclear. This systematic review synthesized current evidence on DL applications for ONFH diagnosis, staging, segmentation, and prognosis across imaging modalities, with emphasis on performance, quality, and explainability.
methodsFollowing PRISMA 2020 guidelines, PubMed, Embase, Scopus, and Web of Science were searched on 18 August 2025. Studies applying DL to MRI, CT or radiograph for ONFH diagnosis, segmentation, staging, or prediction were included. Two reviewers independently conducted screening and data extraction; Methodological quality was appraised using the Must AI Criteria-10 (MAIC-10); Due to heterogeneity, findings were narratively synthesized by imaging modality and analytical task.
resultsAmong 301 records, 26 studies met inclusion criteria (1993-2025). MRI was the most used modality (n = 14), followed by radiography (n = 7), CT (n = 2), and multimodal frameworks (n = 3). Diagnostic AUCs typically ranged from 0.89 to 0.98, while necrotic-lesion segmentation performance yielded Dice scores between 0.57 and 0.75. Anatomical segmentation (femur or femoral head) achieved much higher Dice values (0.90-0.99). MRI-based models achieved the highest sensitivity for early and pre-collapse detection, while radiograph-based madules showed strong specificity and scalability on large datasets (up to 59372 images). CT and multimodal pipelines improved anatomical delineation, volumetric mapping, and cross-domain precision. Predictive models integrating imaging and clinical data achieved AUCs of 0.85-0.95 for outcome or collapse prediction. The mean MAIC-10 score was 6.27/10, indicating moderate methodological quality, with consistent strengths in clinical relevance but limited external validation, explainability and uncertainty quantification.
conclusionsDL shows promising internal diagnostic and staging performance for ONFH and growing potential in prognostic modeling. However, most studies remain retrospective and single-center, limited by small and heterogeneous datasets. Future research should prioritize multicenter validation, standardized reporting, and uncertainty estimation to advance clinically explainable and generalizable DL tools for musculoskeletal imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.